(Q58599459)

English

Nivolumab plus ipilimumab or nivolumab alone versus ipilimumab alone in advanced melanoma (CheckMate 067): 4-year outcomes of a multicentre, randomised, phase 3 trial

scientific article published on 22 October 2018

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30361170%20AND%20SRC:MED&resulttype=core&format=json

30 April 2020

Nivolumab plus ipilimumab or nivolumab alone versus ipilimumab alone in advanced melanoma (CheckMate 067): 4-year outcomes of a multicentre, randomised, phase 3 trial (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30361170%20AND%20SRC:MED&resulttype=core&format=json

30 April 2020

phase III clinical trial

1 reference

based on heuristic

inferred from title

multicenter clinical trial

1 reference

based on heuristic

inferred from title

Vanna Chiarion Sileni

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30361170%20AND%20SRC:MED&resulttype=core&format=json

30 April 2020

Piotr Rutkowski

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30361170%20AND%20SRC:MED&resulttype=core&format=json

30 April 2020

Pier Francesco Ferrucci

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30361170%20AND%20SRC:MED&resulttype=core&format=json

30 April 2020

Ivan Marquez-Rodas

15

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30361170%20AND%20SRC:MED&resulttype=core&format=json

30 April 2020

Jedd D. Wolchok

19

object named as

Jedd D Wolchok

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30361170%20AND%20SRC:MED&resulttype=core&format=json

30 April 2020

Reinhard Dummer

10

object named as

Reinhard Dummer

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30361170%20AND%20SRC:MED&resulttype=core&format=json

30 April 2020

Dirk Schadendorf

8

object named as

Dirk Schadendorf

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30361170%20AND%20SRC:MED&resulttype=core&format=json

30 April 2020

author name string

Frank Stephen Hodi

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30361170%20AND%20SRC:MED&resulttype=core&format=json

30 April 2020

Rene Gonzalez

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30361170%20AND%20SRC:MED&resulttype=core&format=json

30 April 2020

Jean-Jacques Grob

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30361170%20AND%20SRC:MED&resulttype=core&format=json

30 April 2020

Charles Lance Cowey

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30361170%20AND%20SRC:MED&resulttype=core&format=json

30 April 2020

Christopher D Lao

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30361170%20AND%20SRC:MED&resulttype=core&format=json

30 April 2020

John Wagstaff

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30361170%20AND%20SRC:MED&resulttype=core&format=json

30 April 2020

Michael Smylie

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30361170%20AND%20SRC:MED&resulttype=core&format=json

30 April 2020

Andrew Hill

13

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30361170%20AND%20SRC:MED&resulttype=core&format=json

30 April 2020

David Hogg

14

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30361170%20AND%20SRC:MED&resulttype=core&format=json

30 April 2020

Joel Jiang

16

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30361170%20AND%20SRC:MED&resulttype=core&format=json

30 April 2020

Jasmine Rizzo

17

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30361170%20AND%20SRC:MED&resulttype=core&format=json

30 April 2020

James Larkin

18

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30361170%20AND%20SRC:MED&resulttype=core&format=json

30 April 2020

language of work or name

0 references

publication date

22 October 2018

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30361170%20AND%20SRC:MED&resulttype=core&format=json

30 April 2020

Lancet Oncology Commission

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30361170%20AND%20SRC:MED&resulttype=core&format=json

30 April 2020

19

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30361170%20AND%20SRC:MED&resulttype=core&format=json

30 April 2020

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30361170%20AND%20SRC:MED&resulttype=core&format=json

30 April 2020

1480-1492

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30361170%20AND%20SRC:MED&resulttype=core&format=json

30 April 2020

Systematic review of medical treatment in melanoma: current status and future prospects.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2818%2930700-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Pooled Analysis of Long-Term Survival Data From Phase II and Phase III Trials of Ipilimumab in Unresectable or Metastatic Melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2818%2930700-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Vemurafenib in patients with BRAFV600 mutation-positive metastatic melanoma: final overall survival results of the randomized BRIM-3 study

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2818%2930700-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Immune Checkpoint Blockade in Cancer Therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2818%2930700-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Overall Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2818%2930700-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Pembrolizumab versus ipilimumab for advanced melanoma: final overall survival results of a multicentre, randomised, open-label phase 3 study (KEYNOTE-006).

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2818%2930700-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Dabrafenib plus trametinib versus dabrafenib monotherapy in patients with metastatic BRAF V600E/K-mutant melanoma: long-term survival and safety analysis of a phase 3 study

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2818%2930700-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Combined nivolumab and ipilimumab versus ipilimumab alone in patients with advanced melanoma: 2-year overall survival outcomes in a multicentre, randomised, controlled, phase 2 trial

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2818%2930700-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy and Safety Outcomes in Patients With Advanced Melanoma Who Discontinued Treatment With Nivolumab and Ipilimumab Because of Adverse Events: A Pooled Analysis of Randomized Phase II and III Trials

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2818%2930700-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2818%2930700-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Measuring diagnostic and predictive accuracy in disease management: an introduction to receiver operating characteristic (ROC) analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2818%2930700-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Time-dependent ROC curves for censored survival data and a diagnostic marker

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2818%2930700-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-Term Outcomes in Patients With BRAF V600-Mutant Metastatic Melanoma Who Received Dabrafenib Combined With Trametinib

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2818%2930700-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Safety of resuming anti-PD-1 in patients with immune-related adverse events (irAEs) during combined anti-CTLA-4 and anti-PD1 in metastatic melanoma.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2818%2930700-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S1470-2045(18)30700-9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30361170%20AND%20SRC:MED&resulttype=core&format=json

30 April 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30361170%20AND%20SRC:MED&resulttype=core&format=json

30 April 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q58599459&oldid=2167962140"